![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Treatment of renal calcium stone disease with the synthetic glycosaminoglycan pentosan polysulphate
Glycosaminoglycans (GAGs) are potent inhibitors of calcium oxalate growth and aggregation. The synthetic GAG pentosan polysulphate (PPS) was used in the treatment of patients with renal calcium stone disease. ...
-
Chapter and Conference Paper
Clinical characteristics of renal stone disease in relation to urinary oxalate excretion
The formation of calcium-containing renal stones is regarded as a multifactorial process involving high urinary concentrations of calcium and oxalate in combination with reduced excretion of inhibitory factors...
-
Chapter and Conference Paper
The importance of residual calculi on recurrence in patients with infection stones
Traditionally the purpose in all kind of renal stone surgery is to achieve complete clearance of the kidney. It is, of course, still an important task to remove the stone fragments, although in newer operative...
-
Chapter and Conference Paper
Effects of Phosphate Treatment in Calcium Urolithiasis
Phosphate salts have been proposed for prophylactic treatment of renal calcium stone disease for many years.1 Originally, this treatment was based on phosphates effect of reducing the urinary excretion of calcium...
-
Chapter and Conference Paper
The interaction of urinary inhibitors with crystals
It has been proposed that hyperuricosuria may promote calcium oxalate stone formation. One of the suggested mechanisms is an interference between urate microcrystals and naturally occurring macromolecular inhi...
-
Chapter and Conference Paper
Renal handling of urate in renal stone patients during treatment with thiazides
It is well known that thiazide treatment raises the serum urate levels (1). It has also been reported that the urinary excretion of urate is enhanced during long-term thiazide therapy (2). Such an increase mig...
-
Chapter and Conference Paper
Prophylactic treatment of renal stone disease with magnesium hydroxide during five years
Already in the year 1810 (Brande) was magnesium proposed as prophylactic treatment against renal stone disease. It was later shown that magnesium increased the solubility of calcium oxalate in vitro (Hammarsten, ...
-
Chapter and Conference Paper
Renal Tubular Handling of Urate in Calcium Stone Formers with Hyperuricosuria or Renal Acidification Defects
Hyperuricosuria has been considered as a risk factor for calcium stone formation (1) and thought to be mainly a result of consumption of purine rich animal protein (2). According to Coe (3) some hyperuricosuri...